FDA Issues Work Plan For Independent Assessment Of Pre-market Review Process
This article was originally published in The Gray Sheet
Executive Summary
The assessment, called for by industry during the device user fee reauthorization, will be conducted by an independent consulting firm. The goal is to identify efficiencies in the device review process.